Literature DB >> 21959282

Achilles heel of Ebola viral entry.

Alexandra Flemming.   

Abstract

Entities:  

Year:  2011        PMID： 21959282     DOI： 10.1038/nrd3568

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.

Authors:  Jan E Carette; Matthijs Raaben; Anthony C Wong; Andrew S Herbert; Gregor Obernosterer; Nirupama Mulherkar; Ana I Kuehne; Philip J Kranzusch; April M Griffin; Gordon Ruthel; Paola Dal Cin; John M Dye; Sean P Whelan; Kartik Chandran; Thijn R Brummelkamp
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

2.  Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.

Authors:  Marceline Côté; John Misasi; Tao Ren; Anna Bruchez; Kyungae Lee; Claire Marie Filone; Lisa Hensley; Qi Li; Daniel Ory; Kartik Chandran; James Cunningham
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962
  2 in total
  3 in total

1.  THE STRENGTHS, WEAKNESSES, OPPORTUNITIES, AND THREATS (SWOTs) ANALYSES OF THE EBOLA VIRUS - PAPER RETRACTED.

Authors:  Michael Oluyemi Babalola
Journal:  Afr J Infect Dis       Date:  2016-05-01

2.  Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro.

Authors:  Susann Kummer; Angelika Lander; Jonas Goretzko; Norman Kirchoff; Ursula Rescher; Sebastian Schloer
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 3.  Repurposing Antifungals for Host-Directed Antiviral Therapy?

Authors:  Sebastian Schloer; Jonas Goretzko; Ursula Rescher
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.